(Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant, a novel, once-daily oral ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase II drugs for ...

Check out our top picks below. This supplement is a unique blend of bovine whole adrenal and cortex designed to provide support to your adrenal glands and gland function as well as stress management.

The Pure Encapsulations Adrenal Cortex Supplement is a unique supplement designed to provide support to your adrenal glands and gland function as well as stress management. The supplement is made ...

Dostarlimab is under clinical development by GSK and currently in Phase II for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase II drugs for Adrenocortical Carcinoma ...

serious and lifelong genetic condition involving the adrenal glands. The company noted that CRENESSITY, a potent and selective oral corticotropin-releasing factor type 1 receptor (CRF1 ...